Christina Markus and Geneviève Michaux to Speak at two European Cell and Gene Therapy Research Consortia

On April 2, Christina Markus and Geneviève Michaux presented on price transparency to two public-private European research consortia that focus on lymphoid malignancies and oncology cell and gene therapies. These research consortia, which include major public hospitals and research institutes, are concerned that certain lack of price transparency hinders prescriptions of supposedly expensive products such as cell and gene therapies and wanted to understand whether the new U.S. pricing environment might trigger more transparency in Europe. Chris Markus summarized the evolving U.S. price regulations for pharmaceuticals, focusing on transparency rules and cell and gene therapy products. Geneviève Michaux then elaborated the impact that U.S. regulation may have on Europe and in particular on cell and gene therapy products.  The audience included approximately 20 members of the consortia.